Amarantus Bioscience Holdings Inc (AMBS)

[betelgeuse]

GIA is an option for sure, just that is not on the horizon by a long long shot. AMBS needs a worldwide distributor for LymPro.

I can now confirm (people can question, but that is not my problem) that LymPro analytical performance in BD lab has returned stupendous numbers. The 96/98 % specificity/sensitivity has been replicated, confirming AMBS's previous study with 160 patient population.The focus has now shifted to who AMBS selects to carry out the CLIA work which should bring some decent funding to AMBS.

By the way, the recent run from 0.03 to 0.09 was not a fluke. Gerald was invited all the way to Helsinki not to just sit on a Alz discussion for 1 hour. Yesterday's little 30% stunt was staged by crooks. It is a shame such things are allowed by SEC. Watch out for some real fun, real soon. It is time to be pleasantly surprised.